# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-066564
Filing Date
2024-05-30
Accepted
2024-05-30 16:05:22
Documents
16
Period of Report
2024-07-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | eldn-20240530.htm iXBRL | DEF 14A | 1202917
2 | GRAPHIC | img117103358_0.jpg | GRAPHIC | 191772
3 | GRAPHIC | img117103358_1.jpg | GRAPHIC | 143022
4 | GRAPHIC | img117103358_2.jpg | GRAPHIC | 140421
5 | GRAPHIC | img117103358_3.jpg | GRAPHIC | 936544
6 | GRAPHIC | img117103358_4.jpg | GRAPHIC | 520524
| Complete submission text file | 0000950170-24-066564.txt |  | 6476954

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eldn-20240530.xsd | EX-101.SCH | 21699
19 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20240530_htm.xml | XML | 308283

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 241005175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)